Latest News for: Finance pharma

Edit

APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed

Pharmiweb 08 May 2024
APONTIS PHARMA AG / Key word(s) ... EUR 20.8 million), APONTIS PHARMA continues to have a solid asset and financial position to finance the further growth planned and the expansion of the product portfolio ... About APONTIS PHARMA..
Edit

Rett Syndrome Pipeline Assessment, 2024 Updates | Clinical Trials, Drugs, Latest FDA Approvals, Companies | ...

GetNews 07 May 2024
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Rett Syndrome market.
Edit

Retinitis Pigmentosa Pipeline Assessment, 2024 Updates | In-depth Insights Into the Clinical Trials, Emerging Drugs, ...

GetNews 06 May 2024
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Retinitis Pigmentosa market.
Edit

Metastatic Melanoma Pipeline Assessment, 2024 Updates | In-depth Insights Into the Clinical Trials, Emerging Drugs, ...

GetNews 06 May 2024
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Metastatic Melanoma market.
Edit

Sensex falls over 1,000 points, Nifty loses 200: Why is stock market falling

Hindustan Times 03 May 2024
Nifty Financial Services rose over 1% higher, Nifty Bank was up 0.5% while Nifty Auto, Media, Metal, Pharma, and Realty opened with gains. Bajaj Finance soars ... Bajaj Finance share price soars 7% following RBI ban reversal.
Edit

SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations

Pharmiweb 30 Apr 2024
SCHOTT Pharma AG & Co ... SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations ... “Tobias joining our finance team is a real win for SCHOTT Pharma ... Almuth Steinkühler, CFO of SCHOTT Pharma ... About SCHOTT Pharma ... SCHOTT Pharma AG & Co.
Edit

ChrysCapital closes its continuation fund at $700 million

Live Mint 30 Apr 2024
ChrysCap, Kedaara prepare their biggest funds everFounded in 1999, ChrysCapital has raised over $5 billion across nine funds and backed marquee companies including Infosys Ltd, Hexaware Technologies ...
Edit

Metastatic Colorectal Cancer Pipeline 2024 | Pfizer, Sanofi, Taiho Pharma, Ono Pharma, Hutchison Medipharma, Isofol ...

GetNews 30 Apr 2024
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and ...
Edit

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024

Pharmiweb 25 Apr 2024
Heidelberg Pharma AG / Key word(s) ... Heidelberg Pharma AG ... Heidelberg Pharma AG ... Ladenburg, Germany, 25 April 2024 - Heidelberg Pharma AG (FSE ... Professor Andreas Pahl, CEO of Heidelberg Pharma AG, commented ... About Heidelberg Pharma ... Heidelberg Pharma AG.
Edit

Chronic Lymphocytic Leukemia Clinical Updates 2024 | FDA Approvals, Therapies in Focus, Octapharma, Celgene, Loxo ...

GetNews 25 Apr 2024
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and ...
Edit

Pancreatic Ductal Adenocarcinoma Clinical Trial Updates 2024 | Fda Approvals, Therapies in Focus, Cardiff Oncology, ...

GetNews 25 Apr 2024
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and ...
×